PARP1 and cancer: D’Andrea et al. [148] additionally demonstrated that the overexpression of NNMT in mesenchymal cancer stem cells depleted the intracellular NAM, which enhanced the PARP1 activity and increased the cancer cell resistance to chemoradiotherapy.